559 related articles for article (PubMed ID: 8096092)
1. [Local or systemic treatment of inflammatory bowel diseases?].
Schmassmann A; Halter F
Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
[TBL] [Abstract][Full Text] [Related]
2. [Conservative therapy of ulcerative colitis and Crohn disease].
Rasenack J; Kreisel W
Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
Fischbach W
Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
[TBL] [Abstract][Full Text] [Related]
4. Medical management of patients with difficult-to-treat inflammatory bowel disease.
van Hogezand RA
Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
[TBL] [Abstract][Full Text] [Related]
5. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
6. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
7. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Maier K; Fischer C; Klotz U; Heinkel K
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
[TBL] [Abstract][Full Text] [Related]
8. Medical therapy for ulcerative colitis in childhood.
Ament ME; Vargas JH
Semin Pediatr Surg; 1994 Feb; 3(1):28-32. PubMed ID: 7914811
[TBL] [Abstract][Full Text] [Related]
9. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Schölmerich J
Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapy for inflammatory bowel disease.
Hirschfeld S; Clearfield HR
Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
[TBL] [Abstract][Full Text] [Related]
11. [Drug therapy of ulcerative colitis].
Rückert Y
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
Schölmerich J; Gerok W
Wien Klin Wochenschr; 1986 Nov; 98(22):762-9. PubMed ID: 2880425
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
14. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
Seibold F; Wagner AC; Göke B
Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
16. Topical salicylate therapy (4-ASA and 5-ASA enemas).
Ginsberg AL
Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
[TBL] [Abstract][Full Text] [Related]
17. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
Bayerdörffer E; Bock H
Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine and 5-ASA compounds.
Allgayer H
Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
[TBL] [Abstract][Full Text] [Related]
19. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
Marshall JK; Irvine EJ
Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
[TBL] [Abstract][Full Text] [Related]
20. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
